P50 CA090578/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	2
2007	2
2008	13
2009	21
2010	34
2011	27
2012	37
2013	43
2014	31
2015	23
2016	22
2017	15
2018	12
2019	9
2020	10
2021	5
2022	1
2024	0

1

Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients.

Du H, Mu R, Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Li H, Wei Q. Du H, et al. Transl Lung Cancer Res. 2022 May;11(5):890-901. doi: 10.21037/tlcr-22-104. Transl Lung Cancer Res. 2022. PMID: 35693292 Free PMC article.

2

Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.

Mu R, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Du M, Christiani DC, Jin L, Wei Q. Mu R, et al. Int J Cancer. 2021 Sep 15;149(6):1302-1312. doi: 10.1002/ijc.33702. Epub 2021 Jun 10. Int J Cancer. 2021. PMID: 34058013 Free PMC article.

3

Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.

Yang S, Tang D, Zhao YC, Liu H, Luo S, Stinchcombe TE, Glass C, Su L, Shen S, Christiani DC, Wang Q, Wei Q. Yang S, et al. Cancer Immunol Immunother. 2021 Oct;70(10):2819-2833. doi: 10.1007/s00262-021-02877-9. Epub 2021 Mar 2. Cancer Immunol Immunother. 2021. PMID: 33651148 Free PMC article.

4

Rare deleterious germline variants and risk of lung cancer.

Liu Y, Xia J, McKay J, Tsavachidis S, Xiao X, Spitz MR, Cheng C, Byun J, Hong W, Li Y, Zhu D, Song Z, Rosenberg SM, Scheurer ME, Kheradmand F, Pikielny CW, Lusk CM, Schwartz AG, Wistuba II, Cho MH, Silverman EK, Bailey-Wilson J, Pinney SM, Anderson M, Kupert E, Gaba C, Mandal D, You M, de Andrade M, Yang P, Liloglou T, Davies MPA, Lissowska J, Swiatkowska B, Zaridze D, Mukeria A, Janout V, Holcatova I, Mates D, Stojsic J, Scelo G, Brennan P, Liu G, Field JK, Hung RJ, Christiani DC, Amos CI. Liu Y, et al. NPJ Precis Oncol. 2021 Feb 16;5(1):12. doi: 10.1038/s41698-021-00146-7. NPJ Precis Oncol. 2021. PMID: 33594163 Free PMC article.

5

Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.

Hung RJ, Warkentin MT, Brhane Y, Chatterjee N, Christiani DC, Landi MT, Caporaso NE, Liu G, Johansson M, Albanes D, Marchand LL, Tardon A, Rennert G, Bojesen SE, Chen C, Field JK, Kiemeney LA, Lazarus P, Zienolddiny S, Lam S, Andrew AS, Arnold SM, Aldrich MC, Bickeböller H, Risch A, Schabath MB, McKay JD, Brennan P, Amos CI. Hung RJ, et al. Cancer Res. 2021 Mar 15;81(6):1607-1615. doi: 10.1158/0008-5472.CAN-20-1237. Epub 2021 Jan 20. Cancer Res. 2021. PMID: 33472890 Free PMC article.

6

Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.

Wu Y, Liu Z, Tang D, Liu H, Luo S, Stinchcombe TE, Glass C, Su L, Lin L, Christiani DC, Wang Q, Wei Q. Wu Y, et al. Transl Res. 2021 Jul;233:92-103. doi: 10.1016/j.trsl.2020.12.009. Epub 2021 Jan 2. Transl Res. 2021. PMID: 33400994 Free PMC article.

7

Genetic variants of BIRC3 and NRG1 in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survival.

Tang D, Liu H, Zhao Y, Qian D, Luo S, Patz EF Jr, Su L, Shen S, ChristianI DC, Gao W, Wei Q. Tang D, et al. Am J Cancer Res. 2020 Aug 1;10(8):2582-2595. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905523 Free PMC article.

8

Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.

Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Lin L, Christiani DC, Wei Q. Liu L, et al. Am J Cancer Res. 2020 Aug 1;10(8):2603-2616. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905494 Free PMC article.

9

IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells.

Rodrigues FS, Miranda VS, Carneiro-Lobo TC, Scalabrini LC, Kruspig B, Levantini E, Murphy DJ, Bassères DS. Rodrigues FS, et al. Int J Mol Sci. 2020 Aug 13;21(16):5806. doi: 10.3390/ijms21165806. Int J Mol Sci. 2020. PMID: 32823550 Free PMC article.

10

Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival.

Qian D, Liu H, Zhao L, Wang X, Luo S, Moorman PG, Patz EF Jr, Su L, Shen S, Christiani DC, Wei Q. Qian D, et al. Transl Lung Cancer Res. 2020 Jun;9(3):575-586. doi: 10.21037/tlcr-19-318. Transl Lung Cancer Res. 2020. PMID: 32676321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

285 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year